Planta Med 2006; 72(13): 1181-1187
DOI: 10.1055/s-2006-947201
Original Paper
Pharmacology
© Georg Thieme Verlag KG Stuttgart · New York

Gigantol Isolated from the Whole Plants of Cymbidium goeringii Inhibits the LPS-Induced iNOS and COX-2 Expression via NF-κB Inactivation in RAW 264.7 Macrophages Cells

Jong-Heon Won1 , Ji-Yeon Kim1 , Kyung-Jin Yun1 , Jin-Hee Lee2 , Nam-In Back2 , Hae-Gon Chung3 , Sun A. Chung3 , Tae-Sook Jeong4 , Myung-Sook Choi5 , Kyung-Tae Lee1
  • 1College of Pharmacy, Kyung-Hee University, Hoegi-Dong, Seoul, Republic of Korea
  • 2Graduate School of Biotechnology & Plant Metabolism Research Center, Kyung-Hee University, Suwon, Republic of Korea
  • 3Gangwha Agricultural R&D Center, Incheon, Korea
  • 4National Research Laboratory of Lipid Metabolism & Atherosclerosis, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea
  • 5Department of Food Science and Nutrition, Kyungpook National University, Daegu, Republic of Korea
Weitere Informationen

Publikationsverlauf

Received: April 19, 2006

Accepted: June 20, 2006

Publikationsdatum:
21. August 2006 (online)

Preview

Abstract

During our efforts to find bioactive natural products with anti-inflammatory activity, we isolated gigantol from the whole plants of Cymbidium goeringii (Orchidaceae) by activity-guided chromatographic fractionation. Gigantol was found to have potent inhibitory effects on LPS-induced nitric oxide (NO) and prostaglandin E2 (PGE2) production in RAW 264.7 cells. Consistent with these findings, gigantol suppressed the expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) at the protein and mRNA levels in RAW 264.7 cells in a concentration-dependent manner. Our data also indicate that gigantol is a potent inhibitor of tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β) and interleukin-6 (IL-6) release and influenced the mRNA expression levels of these cytokines in a dose-dependent manner. Furthermore, a reporter gene assay for nuclear factor kappa B (NF-κB) and an electromobility shift assay (EMSA) demonstrated that gigantol effectively inhibited the activation of NF-κB, which is necessary for the expression of iNOS, COX-2, TNF-α, IL-1β and IL-6. Thus, our studies suggest that gigantol inhibits LPS-induced iNOS and COX-2 expression by blocking NF-κB activation.

References

Kyung-Tae Lee, Ph. D.

Department of Pharmaceutical Biochemistry

College of Pharmacy

Kyung-Hee University

Dongdaemun-Ku

Hoegi-Dong 130-701

Seoul

Korea

Telefon: +82-2-961-0860

Fax: +82-2-966-3885

eMail: ktlee@khu.ac.kr